GAGs showed dose-dependent inhibition of CSC growth. The cells were grown in CSC media under non-adherent conditions in the presence of GAGs (0→500 µM) for 72 hr. b. HS06 shows significantly greater growth inhibition in spheroid compared to monolayer condition in a dose-dependent fashion. HS = heparan sulfate; CS = chondroitin sulfate; DS = dermatan sulfate. Data is normalized to vehicle control. Error bars represent ±1 SEM. * p-value < 0.005. Figure S3 : Primary (1°), secondary (2°) and tertiary (3°) screening of the growth of colorectal HCT116 cells under spheroid conditions. 1 screening was performed in the presence of 100 μM sulfated GAG, whereas 2° and 3° spheroid growth was performed in the absence of further GAG treatment in HCT116 cells (p53 wild type, K-RAS mutant, microsatellite stable). HS06 was the only GAG that satisfied the predefined cutoff of >50% inhibition in both 2° and 3° spheroids growth. Data is presented as percent of the vehicle control. Error bars represent ±1 SEM.
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